Key Highlights

  • Mayne Pharma signed a binding agreement to sell Mayne Pharma International to Evaris Pharma for $55.5 million in cash.
  • Atomos launched seven Flanders Scientific monitors priced up to 30% below the VP Series equivalent XMP model and up to 48% below for the V Series.
  • Dotz Nano signed a five-year ChillerAI services agreement with Africa Israel Hotels covering six hotels.
  • Completion or commencement steps remain subject to regulatory approval, installation or shipping timelines.

Three small-cap ASX companies announced transactions or product developments on 6 November 2026. Mayne Pharma Group (ASX:MYX) agreed to divest its international segment, Atomos Limited (ASX:AMS) launched a new range of reference monitors, and Dotz Nano Limited (ASX:DTZ) signed a performance-based energy-efficiency agreement with a hotel group.

Mayne Pharma Agrees to Sell Its International Segment

Mayne Pharma entered a binding share sale agreement with an entity owned by General Pharma Bidco, trading as Evaris Pharma, for the sale of Mayne Pharma International Pty Ltd for $55.5 million cash at completion, subject to Working Capital adjustments. The segment comprises contract development and Manufacturing operations and Australian and international commercial operations centred on the Salisbury Facility in South Australia. It recorded FY26 Revenue of $70.7 million and direct contribution of $4.6 million.

Mayne Pharma will retain its US Women's Health and Dermatology businesses, including the DistributeRx direct-to-patient platform, and says the sale completes its move to a Business focused entirely on the United States. A Supply agreement will continue the manufacture of DORYX MPC and TOLSURA at Salisbury, with transitional services and Brand licence arrangements for a limited period. Completion is expected in the third quarter of FY27, subject to ACCC determination. FIRB approval, Shareholder approval and a financing condition are not required. The process followed the termination of a scheme implementation deed in December 2025.

Atomos Launches Seven New Monitors

Atomos announced that its Flanders Scientific brand released seven professional reference monitors across two new ranges, the VP Series and the V Series. The VP range includes the VP270, VP310, VP551 and VP651, while the V range includes the V270, V310 and V550. Shipping begins in November 2026. The company described the release as the largest single product launch in its history.

The monitors use the same QD-OLED panels, colour technology and calibration capability as the flagship XMP Series, with a narrower feature set. US list prices run from US$5,995 for the V270 to US$17,495 for the VP651. Against the equivalent XMP model, the VP270 is priced at US$7,995 versus US$11,495, and the V270 at US$5,995 versus US$11,495. The XMP and XMP C ranges remain in production, and management said it expects Demand to be additional to the existing customer base.

The VP551 and VP651 are 55-inch and 65-inch models with peak luminance of 4,000 nits, while the VP270 and VP310 and the V270 and V310 reach 1,000 nits and the V550 reaches 2,000 nits.

Dotz Nano Signs a ChillerAI Agreement

Dotz Nano's Israeli Subsidiary agreed to supply, install and operate its ChillerAI dynamic chiller-management system for the Africa Israel Hotels group under a five-year agreement. The schedule lists six properties, VERT Jerusalem, VERT Eilat, VERT Lagoon Netanya, VERT Dead Sea, Crowne Plaza Tel Aviv City Center and POLI Urban Tel Aviv, with about 3,705 tons of installed cooling capacity. VERT Jerusalem is the initial site.

Revenue is performance-based. Dotz will receive a monthly fee equal to 40% of measured savings in air-conditioning electricity use, with no installation fee. Indicative monthly fees across the six hotels total about NIS 32,176, or roughly A$14,500, which the company equates to $174,000 a year. Installation is due within 60 business days, and fees start after a baseline measurement period of about 30 days. The hotel group may exit every 12 months on one month's written notice, and commencement depends on approval of Dotz's monitoring dashboard. The system was installed previously at VERT Jerusalem and VERT Lagoon Netanya under a 2023 proposal.

Dotz said the agreement fits its aim of building Recurring Revenue from ChillerAI deployments in large commercial buildings, alongside its activities in Cyprus with Thanos Hotels and MyMall.

What Remains Outstanding

Each announcement leaves defined steps to complete: ACCC clearance for Mayne Pharma, shipments of the new monitors for Atomos, and installation, dashboard approval and baseline measurement for Dotz.